title: Comment on: real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome: reply.
authors.affiliation: Division of Paediatric Rheumatology, University Children's Hospital Tübingen, Tübingen, Germany kuemmerle.deschner@uni-tuebingen.de.
authors.forename: Jasmin B
authors.initials: JB
authors.lastname: Kuemmerle-Deschner
authors.affiliation: Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.
authors.forename: Susanne M
authors.initials: SM
authors.lastname: Benseler
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D056587:Cryopyrin-Associated Periodic Syndromes; D006801:Humans; D053583:Interleukin-1beta
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053583:Interleukin-1beta; C541220:canakinumab